RankingsPricing
  1. US-listed companies
  2. AYTU BIOPHARMA, INC

AYTU BIOPHARMA, INCAYTU

Market cap
$13.75M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Aug 31,
2013		Jun 30,
2015		Jun 30,
2016		Jun 30,
2017		Jun 30,
2018		Jun 30,
2019		Jun 30,
2020		Jun 30,
2021		Jun 30,
2022		Jun 30,
2023
Cash and cash equivalents-78802,32871148501923
Accounts receivable, net-157,058162,427528,039578,78225282229
Inventories-39,442524,70711110161112
Prepaid expenses-370,888-----1078
Other current assets------6111
Total current assets1,8628103915751056073
Property and equipment, net-------532
Operating lease right-of-use asset------634,093432
Intangible assets, net-------857159
Other non-current assets--119111917011
Total non-current assets7,8071014121219781607864
Total assets9,6691824152135153266138136
Accounts payable and other--------1113
Accrued liabilities---782,536185,88218514447
Short-Term Debt---------2
Current portion of debt-------1700
Other current liabilities------839,734-57
Total current liabilities120,525110435281096469
Debt, net of current portion-------01415
Derivative warrant liabilities--275,992-93,98113,20111,371--6
Other non-current liabilities------50137
Total liabilities-31411828581289297
Preferred Stock, Value, Issued-----359----
Common Stock, Value, Issued414,0271,426374821791,75412,584000
Additional paid-in capital40,821395773----335343
Accumulated deficit-500-18,381,341-46,561,425-69,069,729-79,257,592-106,389,500-120,010,179-178-288-304
Total stockholders' equity-110,85616104137951384639
Total liabilities and stockholders' equity9,6691824152135153266138136